{"name":"Tremeau Pharmceuticals, Inc.","slug":"tremeau-pharmceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPcXBkb0lYZWx5VXRaVUlzbnF1UXVFbGYxNkhUNGNVak4yY0lDbV9IUEI4bWFsSFpaR05BZlB2MnJOS2txMUxzb1g4MkZjZ3VaTkg1SE5lY3dMTm13dHRrM1AzOGlxWVRDN2NjNUx2eFZFSVBmZFlDMC1YaUZqRk41OW9PdGF3VXA3V0hqbGpiOFBFNEVNMjV5WmdQMy1Db05sM1J2VFUyNUZpM1gxMmJhejB1NXlTS2M?oc=5","date":"2024-02-16","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Exscientia CEO out after 'inappropriate' relationships with 2 staffers - Fierce Biotech","headline":"Chutes & Ladders—Exscientia CEO out after 'inappropriate' relationships with 2 staffers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPd0c1bV9qZzFFcklNMkZuRVJyeDAtTl9EblJCNkJlTHRJTDhGaDZLb2U5OHNCb281WE5hZ1M3X0VWb1JmcUNIa2FnVWNOUlRZa3Q0UGxvRGlESUpaS1VQX0h6RWlhTGt3YVA2ZWNuOU5sSUIxZFBWd1dNU3Q3TVhFLXlPUjlBMk9TQnctajdfNEJIM0R2aFRfMEZUVQ?oc=5","date":"2023-07-20","type":"pipeline","source":"citybiz","summary":"Trevena Appoints Mark Corrigan, M.D. to Board of Directors - citybiz","headline":"Trevena Appoints Mark Corrigan, M.D. to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOeGxPM01ZLWhud0ZIbi04bVFSWnNTUTljc1lyU1QzUmtOWk51Z3JrVk9TaVZqVW93VjRXY05vSHE3NkNnak9fLVpVWDJJd3Nfdmg1TXRfX3BNNjY1NGdidzROeng0dUdxSzZQeGM5SnVtZDhHMVdDSnF5MnRvamE1QmFEaDNWX0xJWGlj?oc=5","date":"2022-06-23","type":"pipeline","source":"NeurologyLive","summary":"Reformulating Rofecoxib for the Acute Treatment of Migraine - NeurologyLive","headline":"Reformulating Rofecoxib for the Acute Treatment of Migraine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPWjVzQ09XeHlJX0gtUGNPX3MzbHZvQk9PSWpkNXNPbmFRQW1ud2I3ZDJBbms0SC0wek5oalN2d3pBMFg1RXRSc0dlbnI0WHhfeWJvU2YtcmxPbDFxaWY2UG5GdkJ1YXVlVFJEM2Q0SEVXMGRiTHRkWjl1MGQ1d3gydXpvMXVDMjVUdnV3NkM2QUZ6Sm9qb3dGS3I1S1lTMnBuWld4UmhR?oc=5","date":"2022-06-15","type":"pipeline","source":"NeurologyLive","summary":"Tremeau Pharmaceuticals Gets IND Go-Ahead for Rofecoxib Reformulation, Dubbed TRM-201 - NeurologyLive","headline":"Tremeau Pharmaceuticals Gets IND Go-Ahead for Rofecoxib Reformulation, Dubbed TRM-201","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5zdF8zejZfTnhfYjlyTGkteDAtTkdMUkNrMGFzZmdqWGVlTFdTSWp0Z0xKZW1SVGJhdUkyLS1tU2VDdlBabGl5MkhVZkhKUVlUV0NtU05FX3Z4UzNn?oc=5","date":"2022-06-09","type":"pipeline","source":"Pharmaceutical Executive","summary":"Clinical Composer - Pharmaceutical Executive","headline":"Clinical Composer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNQ1ZqcEZGZVo5dThYcTBsV29MTV8tQ1ZkWjNweUE2bjl5S25NUllFZFdRazFvMFF4cm1yV2x0Tml6RXJEdHJmdUtPZ0kwcmR2YzBfWEdCLVBNVVhSS1hLX3Q2dGNaRXhqU3lDNktrQnlrWml3d0dYUUstakxteXc1TjVGN3U0ZFVtbnVsRmp4SnN3NmxqYWVySU1yVnNIbUpjOEtZRDFRTHpKNUxFOVJzaWxfc19RRndPY2l4TDZUTWM5eUZaYTZCM0pLTm0?oc=5","date":"2022-02-10","type":"pipeline","source":"BioSpace","summary":"Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors - BioSpace","headline":"Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOUGNoUElCM2l2dXk5NV95Tng2clhHM25lWEZwRjZKdDZ6TkZGYWNTOHlnY20zcndFeHRuUXVlcDctaUpQZ2FraUU5bFZRNmRwU2VoMWl3Vk5mREQ5RHFIV2gtZWtBOGdZLXZXZzdQdFgwVENkb2pGVmtOUWp3Y2g0VHZ2UjZvMXJ4aWM0?oc=5","date":"2019-10-09","type":"pipeline","source":"statnews.com","summary":"The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease? - statnews.com","headline":"The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE4yellFZi16YmJ0NVdBV291MFYwUkh1VkFZTUNVdm9wRWxZRFA4YnVDQVdodEpIazNpLWt6a09zZmItSjYyT3FvWmpDb2FXX1NsVkstQTJlaWY4MExlVkpzTVRiRTRyaHBBZnNn?oc=5","date":"2017-11-21","type":"pipeline","source":"statnews.com","summary":"Startup seeking to resurrect Vioxx, arthritis drug pulled from market - statnews.com","headline":"Startup seeking to resurrect Vioxx, arthritis drug pulled from market","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}